765-39-9

Usage

Uses

Used in Chemical Synthesis Industry:
1-Aminopyrrole is used as a key intermediate in the synthesis of various chemical compounds, including pharmaceuticals, agrochemicals, and dyes. Its unique structure allows for versatile chemical reactions, making it a valuable building block in organic chemistry.
Used in Flame-Retardant Applications:
1-Aminopyrrole is used as a component in the preparation of reproducible and high-temperature thermosetting flame-retardant resins. Its incorporation into these resins enhances their flame-retardant properties, making them suitable for use in industries where fire safety is a critical concern, such as construction, electronics, and automotive.

InChI:InChI=1/C4H6N2/c5-6-3-1-2-4-6/h1-4H,5H2

Upstream product

• 885-12-1 1-phthalimidopyrrole 
• 109-97-7 pyrrole 
• 7531-52-4 L-prolinamide 

Downstream Products

• 55872-73-6 2,6-Di-tert-butyl-4-(pyrrol-1-ylimino)-cyclohexa-2,5-dienone 
• 55872-74-7 2,6-Dimethyl-4-(pyrrol-1-ylimino)-cyclohexa-2,5-dienone 
• 149543-55-5 (S)-2-<(Benzyloxycarbonyl)amino>-3-hydroxy-N-(1-pyrrolyl)propanamide 
• 55872-84-9 N,N'-(2-methyl-2,5-cyclohexadiene-1,4-diylidene)bis-1H-pyrrol-1-amine 
• 55872-72-5 1-(1,4-Benzochinon-1-ylimino)-pyrrol 
• 55872-82-7 syn-N,N'-(2,5-cyclohexadiene-1,4-diylidene)bis-1H-pyrrol-1-amine 
• 55872-82-7 anti-N,N'-(2,5-cyclohexadiene-1,4-diylidene)bis-1H-pyrrol-1-amine 
• 181263-64-9 N-(1-pyrrolyl)salicylaldimine 
• 55872-89-4 1-(4-nitrosophenylamino)pyrrole 
• 929558-41-8 ethyl 6-[N-(1H-pyrrol-1-yl)sulfamoyl]-1-cyclohexene-1-carboxylate 
• 156335-37-4 ethyl 1,4-dihydro-4-oxopyrrolo<1,2-b>pyridazine-3-carboxylate 
• 343615-78-1 1-(Pyrrol-1-ylsulfamoyl)-piperidine-2S-carboxylic acid 4-phenylbutyl ester 
• 1246847-10-8 ethyl 4-(4-bromophenyl)pyrrolo[2,1-f]pyridazine-2-carboxylate 
• 1246847-11-9 ethyl 4-phenylpyrrolo[2,1-f]pyridazine-2-carboxylate 

Relevant academic research and scientific papers

HETEROCYCLIC COMPOUNDS

The present invention relates to compounds of the general formula (1) wherein the variables are defined as given in the description and claims. The invention further relates to uses of and to, processes and intermediates related to compounds of the general formula (I), wherein Q is wherein the substituents of I, Ia and Ib are as defined in description and claims.

PYRROLOPYRIDAZINE JAK3 INHIBITORS AND THEIR USE FOR THE TREATMENT OF INFLAMMATORY AND AUTOIMMUNE DISEASES

Disclosed are compounds of formula (I) and pharmaceutically acceptable salts thereof. The compounds of formula (I) inhibit tyrosine kinase activity of JAK3, thereby making them useful for the treatment of inflammatory and autoimmune diseases.

PYRROLOPYRIDAZINE JAK3 INHIBITORS AND THEIR USE FOR THE TREATMENT OF INFLAMMATORY AND AUTOIMMUNE DISEASES

Disclosed are compounds of Formula (I), and pharmaceutically acceptable salts thereof. The compounds of formula (I) inhibit tyrosine kinase activity of JAK3, thereby making them useful for the treatment of inflammatory and autoimmune diseases.

HETEROCYCLIC COMPOUND AS PROTEIN KINASE INHIBITOR

Provided are novel heterocyclic compounds useful as anti-cancer drugs by suppressing protein kinase activities of growth factor receptors such as c-Met, pharmaceutical compositions containing the same, and methods for using the compound.

1,1′-Bipyrroles: Synthesis and stereochemistry

(Chemical Equation Presented) 1,1′-Bipyrrole is synthesized in four steps from hydrazine. A colorless solid, mp 52°C, it sublimes readily at room temperature and forms X-ray quality crystals in which the rings are not coplanar but are nearly orthogonal.

Compounds specific to adenosine A1 receptors and uses thereof

This invention pertains to compounds which specifically inhibit the adenosine A1 receptor and the use of these compounds to treat a disease associated with A1 adenosine receptors in a subject.

Electrophotographic organophotoreceptors with novel charge transport compounds

A novel charge transport compound, a novel process using that novel compound and an organophotoreceptor includes: (a) a novel charge transport compound having the formula ?where R1 and R2 are selected so that R1 and R

Bile-acid derived compounds for enhancing oral absorption and systemic bioavailability of drugs

Disclosed are compounds that exhibit high transport across the intestinal wall of an animal. The compounds may optionally be linked to drugs that are poorly absorbed or poorly transported across the intestinal wall after oral administration to provide for enhanced therapeutic, and optionally prolonged therapeutic, systemic blood concentrations of the drugs upon oral administration of the drug-compound conjugate. Also disclosed are pharmaceutical compositions containing and methods of using such compounds.

Compounds specific to adenosine A1 receptors and uses thereof

This invention pertains to compounds which specifically inhibit the adenosine A1 receptor and the use of these compounds to treat a disease associated with A1 adenosine receptors in a subject.

Tautomerism in the solid state and in solution of a series of 6-aminofulvene-1-aldimines

To study systems able to sustain intramolecular proton-transfer, we have prepared a series of six aminofulvene aldimines including several labeled with 15N and 2H. These compounds show coupling constants through the hydrogen bond, 1hJ(15N-1H) and 2hJ(15N-15N). The position of the tautomeric equilibria, i.e., on what nitrogen atom is the proton, was determined in the solid state and in solution. The crystal structure of N{([5-[(phenylamino)methylene]- 1,3-cyclopentadien-1-yl]methylene})pyrrole-1-amine (3) has been determined by X-ray analysis. In solution, both N-H and C-H tautomers were observed and their structures assigned by NMR spectroscopy. Particularly useful is the value of the 1J(15N-1H) coupling constant.